Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 63

    1.

    Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.

    Smit EF, Socinski MA, Mullaney BP, Myrand SP, Scagliotti GV, Lorigan P, Reck M, Ciuleanu T, von Pawel J, Karaseva NA, Szczesna A, Ohannesian D, Powell E, Hozak RR, Hong S, Guba SC, Thatcher N.

    Ann Oncol. 2011 Dec 19. [Epub ahead of print]

    PMID:
    22186609
    [PubMed - as supplied by publisher]
    2.

    Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development.

    Decoster L, Wauters I, Vansteenkiste JF.

    Ann Oncol. 2012 Jun;23(6):1387-93. Epub 2011 Dec 12.

    PMID:
    22156658
    [PubMed - in process]
    3.

    Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology.

    Jalal SI, Riggs HD, Melnyk A, Richards D, Agarwala A, Neubauer M, Ansari R, Govindan R, Bruetman D, Fisher W, Breen T, Johnson CS, Yu M, Einhorn L, Hanna N.

    Ann Oncol. 2011 Dec 9. [Epub ahead of print]

    PMID:
    22156624
    [PubMed - as supplied by publisher]
    4.

    Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer.

    Hayashi H, Okamoto I, Morita S, Taguri M, Nakagawa K.

    Ann Oncol. 2012 Jun;23(6):1537-41. Epub 2011 Oct 29.

    PMID:
    22039091
    [PubMed - in process]
    5.

    The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials.

    Clarey J, Kao SC, Clarke SJ, Vardy J.

    Ann Oncol. 2012 May;23(5):1229-33. Epub 2011 Oct 10.

    PMID:
    21986095
    [PubMed - in process]
    6.

    Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.

    Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, Gridelli C, Hirsch FR, Jassem J, Kosmidis P, Krzakowski M, Manegold C, Pujol JL, Stahel R, Thatcher N, Vansteenkiste J, Minichsdorfer C, Zöchbauer-Müller S, Pirker R, Zielinski CC; for the Central European Cooperative Oncology Group (CECOG).

    Ann Oncol. 2012 May;23(5):1223-1229. Epub 2011 Sep 22.

    PMID:
    21940784
    [PubMed - as supplied by publisher]
    7.

    Lung cancer physicians' referral practices for palliative care consultation.

    Smith CB, Nelson JE, Berman AR, Powell CA, Fleischman J, Salazar-Schicchi J, Wisnivesky JP.

    Ann Oncol. 2012 Feb;23(2):382-7. Epub 2011 Jul 29.

    PMID:
    21804051
    [PubMed - indexed for MEDLINE]
    8.

    Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck.

    Ng QS, Mandeville H, Goh V, Alonzi R, Milner J, Carnell D, Meer K, Padhani AR, Saunders MI, Hoskin PJ.

    Ann Oncol. 2012 Jan;23(1):231-7. Epub 2011 Jul 15.

    PMID:
    21765046
    [PubMed - indexed for MEDLINE]
    9.

    1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer.

    Stahel R, Thatcher N, Früh M, Le Péchoux C, Postmus PE, Sorensen JB, Felip E; Panel members.

    Ann Oncol. 2011 Sep;22(9):1973-80. Epub 2011 Jul 4.

    PMID:
    21727198
    [PubMed - indexed for MEDLINE]
    10.

    Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80.

    Janssen-Heijnen ML, Maas HA, Siesling S, Koning CC, Coebergh JW, Groen HJ.

    Ann Oncol. 2012 Apr;23(4):954-60. Epub 2011 Jun 20.

    PMID:
    21690233
    [PubMed - in process]
    11.

    Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients.

    Tibaldi C, Giovannetti E, Tiseo M, Leon LG, D'Incecco A, Loosekoot N, Bartolotti M, Honeywell R, Cappuzzo F, Ardizzoni A, Peters GJ.

    Ann Oncol. 2012 Mar;23(3):670-7. Epub 2011 Jun 7.

    PMID:
    21652582
    [PubMed - in process]
    12.

    Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC).

    Gauler TC, Besse B, Mauguen A, Meric JB, Gounant V, Fischer B, Overbeck TR, Krissel H, Laurent D, Tiainen M, Commo F, Soria JC, Eberhardt WE.

    Ann Oncol. 2012 Mar;23(3):678-87. Epub 2011 May 26.

    PMID:
    21617019
    [PubMed - in process]
    13.

    Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy.

    Coudert B, Ciuleanu T, Park K, Wu YL, Giaccone G, Brugger W, Gopalakrishna P, Cappuzzo F; SATURN Investigators.

    Ann Oncol. 2012 Feb;23(2):388-94. Epub 2011 May 24.

    PMID:
    21610154
    [PubMed - indexed for MEDLINE]
    14.

    Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.

    Felip E, Gridelli C, Baas P, Rosell R, Stahel R; Panel Members.

    Ann Oncol. 2011 Jul;22(7):1507-19. Epub 2011 May 2.

    PMID:
    21536661
    [PubMed - indexed for MEDLINE]
    15.

    The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer.

    Powles T, Kayani I, Blank C, Chowdhury S, Horenblas S, Peters J, Shamash J, Sarwar N, Boletti K, Sadev A, O'Brien T, Berney D, Beltran L, Haanen J, Bex A.

    Ann Oncol. 2011 May;22(5):1041-7. Epub 2011 Jan 17.

    PMID:
    21242586
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).

    Le Péchoux C, Laplanche A, Faivre-Finn C, Ciuleanu T, Wanders R, Lerouge D, Keus R, Hatton M, Videtic GM, Senan S, Wolfson A, Jones R, Arriagada R, Quoix E, Dunant A; Prophylactic Cranial Irradiation (PCI) Collaborative Group.

    Ann Oncol. 2011 May;22(5):1154-63. Epub 2010 Dec 7.

    PMID:
    21139020
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials.

    Reiman T, Lai R, Veillard AS, Paris E, Soria JC, Rosell R, Taron M, Graziano S, Kratzke R, Seymour L, Shepherd FA, Pignon JP, Sève P; LACE-Bio Group.

    Ann Oncol. 2012 Jan;23(1):86-93. Epub 2011 Apr 6.

    PMID:
    21471564
    [PubMed - indexed for MEDLINE]
    18.

    A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.

    Manegold C, van Zandwijk N, Szczesna A, Zatloukal P, Au JS, Blasinska-Morawiec M, Serwatowski P, Krzakowski M, Jassem J, Tan EH, Benner RJ, Ingrosso A, Meech SJ, Readett D, Thatcher N.

    Ann Oncol. 2012 Jan;23(1):72-7. Epub 2011 Apr 4.

    PMID:
    21464154
    [PubMed - indexed for MEDLINE]
    19.

    The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival.

    William WN, Kim JS, Liu DD, Solis L, Behrens C, Lee JJ, Lippman SM, Kim ES, Hong WK, Wistuba II, Lee HY.

    Ann Oncol. 2012 Jan;23(1):78-85. Epub 2011 Mar 23.

    PMID:
    21430184
    [PubMed - indexed for MEDLINE]
    20.

    Alcohol consumption and lung cancer risk in never smokers: a meta-analysis.

    Bagnardi V, Rota M, Botteri E, Scotti L, Jenab M, Bellocco R, Tramacere I, Pelucchi C, Negri E, La Vecchia C, Corrao G, Boffetta P.

    Ann Oncol. 2011 Dec;22(12):2631-9. Epub 2011 Mar 22.

    PMID:
    21427064
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk